| Name |
Hidrokortizon Medochemie 100 mg prašak za otopinu za injekciju/infuziju |
| Marketing Authorisation Number |
HR-H-903793564 |
| Active Substance |
natrijev hidrokortizonsukcinat |
| Composition |
jedna bočica sadrži 133,7 mg natrijevog hidrokortizonsukcinata, što odgovara 100 mg hidrokortizona |
| Pharmaceutical Form |
Prašak za otopinu za injekciju / infuziju |
| Manufacturer |
Medochemie Ltd., Agios Athanasios, Limassol, Cipar |
| Marketing Authorisation Holder |
Medochemie Ltd., Constatinoupoleos Str. 1-10, Limassol, Cipar |
| Marketing Authorisation Date |
24.07.2026 |
| MA Period of Validity |
24.07.2031 |
| Classification Number |
UP/I-530-09/24-01/348 |
| Registration Number |
381-12-01/286-26-10 |
| Prescription |
Medicinal product subject to medical prescription |
| Type of prescription |
Medicinal product subject to restricted medical prescription
|
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
not allowed |
| ATC Code |
H02AB09 |
| Marketing status |
Never marketed |
| SmPC |
download |
| PL |
download |
| Public Assessment Report |
download
|
| Summary of risk management plan |
download |